wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26786524-18E79587-24B8-4B63-A183-AD19068BF458
Q26786524-18E79587-24B8-4B63-A183-AD19068BF458
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786524-18E79587-24B8-4B63-A183-AD19068BF458
What's next after metformin? focus on sulphonylurea: add-on or combination therapy
P2860
Q26786524-18E79587-24B8-4B63-A183-AD19068BF458
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26786524-18E79587-24B8-4B63-A183-AD19068BF458
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
135a5e2ce7e1db77f4757f0c83acec3ce4809893
P2860
Efficacy and safety of glimepiride/metformin sustained release once daily vs. glimepiride/metformin twice daily in patients with type 2 diabetes.